- Source: inbox/queue/2026-04-13-omada-glp1-care-track-post-discontinuation-outcomes.md - Domain: health - Claims: 1, Entities: 1 - Enrichments: 0 - Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5) Pentagon-Agent: Vida <PIPELINE>
939 B
939 B
Omada Health
Type: Digital health company
Focus: Employer-sponsored chronic condition management programs
Key Product: Enhanced GLP-1 Care Track with behavioral wraparound
Overview
Omada Health operates digital health programs for chronic condition management, primarily distributed through employer-sponsored benefits. Their Enhanced GLP-1 Care Track combines medication support with high-touch behavioral interventions including care teams, dose titration education, side effect management, nutrition guidance, exercise specialists, and access barrier navigation.
Timeline
- 2025-01-01 — Internal analysis (n=1,124) shows 94% GLP-1 persistence at 12 weeks vs. 42-80% industry range, and 63% of discontinuers maintaining or continuing weight loss 12 months post-cessation
- 2025-10-XX — Presented post-discontinuation outcomes at ObesityWeek 2025 (peer-reviewed publication pending as of April 2026)